Emil Freireich, MD, Oral History Interview, August 06, 2001
Files
Download Navigation Materials and Full Transcript (163 KB)
Loading...
Description
Major Topics Covered:
- The Department of Developmental Therapeutics;
- Building the culture of clinical research; training clinical researchers and physician-scientists ;
- MD Anderson presidents and the history and expansion of MD Anderson ;
- Institutional politics as they influenced: Developmental Therapeutics, individual investigators, the standing of clinical research, the education of physician scientists;
- The ethics of clinical research
Interview Chapters
Chapter 18: Departments Undergoing Change under Charles LeMaistre
Chapter 19: Head of the Adult Leukemia Program and a “Project Reassignment” Year at the NIH
Chapter 20: A “Flexner Report for Cancer” and Commitment to Education
Chapter 21: Views of Charles A. LeMaistre and MD and R. Lee Clark, MD
Chapter 22: An NCI Audit and Problems with a Protocol and Leadership
Identifier
Freireich_03_20110806
Publication Date
8-6-2001
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Freireich, Emil J. MD and Brunet, Lesley W., "Emil Freireich, MD, Oral History Interview, August 06, 2001" (2001). Interview Sessions. 25.
https://openworks.mdanderson.org/mchv_interviewsessions/25
About the Interview
About the Interview Subject
Dr. Emil J Freireich (b. 16 March 1927, in Chicago, Illinois) came to MD Anderson in 1965 to serve as Chief of Research (Hematology) in the Department of Development Therapeutics. He was appointed Professor in the Department of Leukemia in the Division of Cancer Medicine.
A pioneer in clinical oncology research and the development of new treatments, Dr. Freireich is best known for developing an effective treatment –effectively a cure-- for childhood acute lymphoblastic leukemia. Freireich worked closely with Emil Frei, MD, and the collaborators developed the first combination chemotherapy treatments shown to be effective against childhood leukemia.
Dr. Freireich served as head of MD Anderson’s Department of Developmental Therapeutics from 1972-1983, when he became Chairman of the Department of Hematology (1983-1985). He served as Director of the Adult Leukemia Research Program (1985-2015). He served as Special Medical Education Director of Educational Programs in the Division of Academic Affairs (2000-2015). In 2014, Dr. Freireich was honored as a Fellow of the American Association for Cancer Research. He retired in 2016.